London stocks ended Tuesday in mixed territory, amid subdued trading in the absence of significant economic data, leaving ...

US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...

The London-based pharmaceutical company said Blenrep, or belantamab mafodotin, was approved for the treatment of adult patients with multiple myeloma in combination with bortezomib plus dexamethasone, ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

She will officially take up the role from June 1, succeeding Sir Norman Lamb, who retired in March after five years of dedicated service.

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Arexvy, already approved in over 60 countries, was supported by trial data showing safety and immune response in the 50–59 age group. GSK said more than 13 million adults in the US fall into this ...

If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...

London open The FTSE 100 is expected to open 22 points lower on Thursday, having closed up 0.32% on Wednesday at 8,275.60.

Nifty surged 4.5% this week to 23,852, its biggest weekly gain since Feb 2021. HDFC Bank, ICICI Bank, Bharti Airtel and Bajaj ...